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Nucleostemin and GNL3L exercise distinct functions in genome
protection and ribosome synthesis, respectively
Tao Lin1, Lingjun Meng1, Tsung-Chin Lin1, Laura J. Wu1, Thoru Pederson2 and Robert Y. L. Tsai1,*
ABSTRACT
The mammalian nucleolar proteins nucleostemin and GNL3-like
(GNL3L) are encoded by paralogous genes that arose from an
ancestral invertebrate gene, GNL3. Invertebrate GNL3 has been
implicated in ribosome biosynthesis, as has its mammalian
descendent, GNL3L. The paralogous mammalian nucleostemin
protein has, instead, been implicated in cell renewal. Here, we
found that depletion of nucleostemin in a human breast carcinoma
cell line triggers prompt and significant DNA damage in S-phase cells
without perturbing the initial step of ribosomal (r)RNA synthesis and
only mildly affects the total ribosome production. By contrast, GNL3L
depletion markedly impairs ribosome production without inducing
appreciable DNA damage. These results indicate that, during
vertebrate evolution, GNL3L retained the role of the ancestral gene
in ribosome biosynthesis, whereas the paralogous nucleostemin
acquired a novel genome-protective function. Our results provide a
coherent explanation for what had seemed to be contradictory
findings about the functions of the invertebrate versus vertebrate
genes and are suggestive of how the nucleolus was fine-tuned for a
role in genome protection and cell-cycle control as the vertebrates
evolved.
KEY WORDS: Cell cycle, DNA damage, GNL3L, Nucleolus,
Nucleostemin, Ribosomal synthesis
INTRODUCTION
The mammalian proteins nucleostemin, GNL3L and GNL2 (also
known as NGP1) constitute a newly recognized family of GTP-
binding proteins defined by their unique MMR-HSR1 motif and
nucleolar localization. Nucleostemin, the most well-known
member of this family, was discovered as a gene preferentially
expressed in rat embryonic neural stem cells compared with their
differentiated progeny and was also found to be expressed at
elevated levels in many cancer cells (Tsai and McKay, 2002).
Nucleostemin plays an indispensable role in early embryogenesis
and the maintenance of the self-renewal of stem or progenitor cells
(Qu and Bishop, 2012; Tsai, 2011; Zhu et al., 2006). GNL3L was
discovered in a screen for nucleostemin-related genes (Du et al.,
2006; Yasumoto et al., 2007). Later studies revealed that
nucleostemin and GNL3L exist as separate genes only in
vertebrate species (Tsai and Meng, 2009). The invertebrate
genomes for which sequence information is available contain
a common ortholog of nucleostemin and GNL3L, termed
GNL3 collectively or specifically named NS1 in Drosophila
melanogaster (CG3983), NST-1 in Caenorhabditis elegans
(K01C8.9), Nug1 in Saccharomyces cerevisiae and Grn1 in
Schizosaccharomyces pombe (NM_001022573). By contrast, GNL2
represents a single gene product that is highly conserved from yeast
to human. Although many members of the MMR-HSR1 family,
including nucleostemin, GNL3L and GNL2 (Meng et al., 2006),
are capable of binding to GTP, most of them do not possess
intrinsic GTPase activity. For the few that do [i.e. YjeQ (Daigle
et al., 2002), Lsg1 (Reynaud et al., 2005) and Drosophila GNL3
(Rosby et al., 2009)], the detected GTPase activity is relatively
weak.
Nucleostemin, GNL3L and GNL2 proteins are conspicuously
localized in the nucleolus but, like many nucleolus-concentrated
proteins, also shuttle between the nucleolus and the nucleoplasm
(Meng et al., 2007). Because of the nucleolar presence of
nucleostemin, it has always been thought to be involved in
ribosome biogenesis. Of course, such a hypothesis assumes that
proteins stationed in the nucleolus at higher concentration than in
the nucleoplasm are involved in the canonical function of this
nuclear domain (i.e. ribosome synthesis), but we now know that
not all nucleolar proteins serve such a role (Andersen et al., 2005;
Ma and Pederson, 2008; Pederson, 1998; Pederson and Tsai,
2009; Scherl et al., 2002). To date, most of the studies showing a
ribosomal effect of nucleostemin have been performed on
invertebrate GNL3 (i.e. Grn1, NST-1 and NS1). It has been
reported that deletion of Grn1 in S. pombe perturbs 35S
preribosomal (pre-r)RNA processing and nucleolar export of
the Rpl25a (60S) complex (Du et al., 2006). In C. elegans, loss of
NST-1 decreases the levels of 18S and 26S rRNAs (Kudron and
Reinke, 2008), and in Drosophila depletion of NS1 protein results
in nucleolar accumulation of the large ribosomal subunit proteins
L11 and L26 (Rosby et al., 2009). In mammalian cells, a potential
role of nucleostemin in ribosomal synthesis was suggested by a
study showing that prolonged knockdown of nucleostemin
delayed the processing of 32S pre-rRNA to 28S ribosomal
(r)RNA (Romanova et al., 2009a). Although these studies
indicate that the loss of nucleostemin might eventually lead to
the perturbation of ribosomes, they fail to establish a coherent
mechanism or a direct target of nucleostemin action in the
ribosomal-synthetic pathway. Indeed, a direct role of mammalian
nucleostemin in pre-rRNA processing is contradicted by a study
showing that the impaired 35S pre-rRNA processing and Rpl25a
nucleolar export phenotypes of Grn1-null yeast can be restored by
human GNL3L, but not by human nucleostemin (Du et al., 2006).
Moreover, mammalian nucleostemin fails to rescue the growth
phenotype in NST-1-deficient C. elegans, and NST-1 is absent
from nucleolar regions where rRNA transcription and processing
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occur (Kudron and Reinke, 2008). Furthermore, mammalian
nucleostemin is localized in subnucleolar regions that are
deficient in nascent 28S rRNA (Politz et al., 2005). Because of
the paralogous descent of mammalian nucleostemin and GNL3L,
and given the evidence that only GNL3L retains the ribosome-
biosynthesis function of invertebrate GNL3, it is possible that
mammalian nucleostemin might have functionally diverged from
mammalian GNL3L and invertebrate GNL3.
These apparent discrepancies raise the issue that perturbations
in ribosome synthesis observed upon nucleostemin depletion
might not represent a direct effect. In this respect, it is noteworthy
that effects on ribosome synthesis have been observed following
two rounds of RNAi-mediated nucleostemin knockdown over a
period of 5 days (Romanova et al., 2009a; Romanova et al.,
2009b). Motivated by the recent discovery of a role for
nucleostemin in protecting telomeres and the genome integrity
of stem and progenitor cells (Hsu et al., 2012; Lin et al., 2013;
Meng et al., 2013; Yamashita et al., 2013), we began to consider
whether the accumulation of DNA damage, rather than impaired
ribosome production, is actually the initial event following
nucleostemin depletion. Using human breast cancer MDA-MB-
231 cells, we found that DNA damage arises as early as 12 hours
after the initiation of nucleostemin depletion, without incurring a
significant effect on rRNA synthesis or nucleolar structure for up
to 48 hours. By striking contrast, depletion of GNL3L perturbs
the processing of pre-rRNA while evoking little, if any, DNA
damage. Our results thus indicate that, during vertebrate
evolution, nucleostemin acquired a unique role in genome
protection, whereas GNL3L retained a conserved function in
ribosome synthesis.
RESULTS
Loss of nucleostemin elicits a prompt DNA damage response
MDA-MB-231 cells, a human breast carcinoma cell line, were
transfected with nucleostemin-specific (siNS) or with control
scrambled (siScr) siRNA duplexes and were collected for analysis
at 48 hours after transfection. The target specificity of siNS has
been demonstrated previously (Meng et al., 2008), and the
knockdown efficiency in MDA-MB-231 cells is confirmed in
Fig. 1A (by western blotting). Notably, there was a pronounced
elevation in the amount of phosphorylated H2AX (c-H2AX, a
histone modification associated with DNA damage), as shown by
analysis of western blots, and an increased percentage of cells
with c-H2AX foci (from 2.3% to 12.2%, P,0.01) was revealed
by using immunofluorescence (Fig. 1A). Parallel immunostaining
also revealed an increase in the percentage of cells with foci of
the protein ataxia telangiectasia and rad3-related (ATR) (Fig. 1B,
from 5.3% to 30.2%, P,0.01) or with 53BP1 foci (Fig. 1C, from
3.3% to 23.5%, P50.02), both of which are indicative of a DNA
damage response.
DNA damage in S-phase cells is an early event after
nucleostemin depletion
To determine the immediacy of the DNA damage effect and also
to assess whether a particular stage of the cell cycle was
impacted, we quantified the increase in the percentage of c-
H2AX+ cells over 12–48 hours by using FACS. As shown in
Fig. 2A, the percentage of c-H2AX+ cells increased as early as
12 hours after the initiation of nucleostemin knockdown and
continued to rise within the first 48 hours. FACS analysis of
propidium-iodide-stained cells revealed that nucleostemin
depletion resulted in an increase in the percentage of S-phase
cells and a decrease in the percentage of G2/M-phase cells at the
12, 24 and 48-hour time-points, and that there was a decrease in
the percentage of G1/G0 cells only at the 48-hour time-point
(Fig. 2B1,2). This suggested that nucleostemin depletion triggers
replication-dependent DNA damage. To address this possibility,
double-label FACS was performed to measure the cell-cycle
distributions in the c-H2AX+ versus c-H2AX2 subpopulations of
siNS-treated cells (Fig. 2C). The c-H2AX+ nucleostemin-
depleted population contained significantly more S-phase cells
and fewer cells in G1/G0 compared with the c-H2AX2
nucleostemin-depleted population (Fig. 2C3,4). Fig. 2D shows
the percentages of G1-phase versus S-phase cells with c-H2AX
foci as a function of the duration of nucleostemin knockdown. We
found that 24.5% (12 hours) to 40.2% (48 hours) of the S-phase
cells showed c-H2AX+ signals in response to nucleostemin
depletion, compared with only 1.8% (12 hours) to 3.5%
(48 hours) of the G1/G0 cells (Fig. 2D, P,0.01). These results
demonstrate that DNA damage is induced in S-phase cells as
early as 12 hours after nucleostemin depletion commences,
triggering an intra-S-phase cell-cycle arrest. To substantiate the
result that nucleostemin-knockdown-triggered DNA damage
occurs preferentially in S-phase cells, we performed a 30-
minute BrdU pulse on siNS-treated cells, followed by
immunofluorescence with antibodies against 53BP1 and BrdU.
At the 48-hour time-point, 27% of the S-phase (BrdU-labeled)
cells showed an increased number of 53BP1 foci (§5 foci per
cell), whereas only 11% of the non-S-phase cells showed an
increased number of 53BP1 foci (Fig. 2E, P,0.01). The higher
percentage of cells with DNA damage in the non-BrdU-labeled
cell population (Fig. 2E, gray bar) compared with that in the G0/
G1 population as measured by FACS of cells labeled with c-
H2AX and PI (Fig. 2D, gray bar) might be due to the inclusion of
G2/M-phase cells as well as some S-phase cells that were already
arrested at the time of BrdU labeling in the non-BrdU-labeled
population. It might also be due to the different sensitivities of
immunofluorescence versus FACS.
Nucleostemin depletion does not significantly perturb rRNA
biogenesis or nucleolar structure coincident with the
activation of DNA damage
Given the conflicting reports on whether nucleostemin depletion
affects rRNA synthesis (see Introduction), we next measured the
effects of nucleostemin knockdown on the levels of 47S and 45S
pre-rRNAs by real-time RT-PCR. As shown in Fig. 3A (left
panel), the primer pair for Processing Site 1 (PS-1) spans the
junction between the 28S region and the 39 external transcribed
spacer (ETS), and therefore its PCR product reflects only the 47S
primary transcript, whereas the primer pair for PS-2 spans the
junction between the 18S region and the 59 ETS, and therefore it
detects both the 47S and 45S precursors. At 48 hours of
nucleostemin depletion, there was no effect on the level of the
47S primary transcript or on the combined levels of the 47S
primary transcript and the 45S pre-rRNA intermediate (Fig. 3A,
center panel). However, when subjected to two rounds of RNAi-
mediated knockdown, lasting for a total of 6 days (see Materials
and Methods), a significant impairment of rRNA synthesis was
observed (Fig. 3A, right panel).
We then sought to determine whether nucleostemin
knockdown affected the accumulation of processed rRNA in
the nucleus, as would be expected if the ribosomal-synthetic
pathway was inhibited. The experimental design was based on the
uptake of the uridine analog 5-ethynyl-uridine (5-EU), and its
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incorporation into RNA, followed by detection of the newly
synthesized RNA in fixed cells by a click-chemistry-mediated dye-
coupling reaction (Jao and Salic, 2008). Moreover, we reasoned
that, because rRNA synthesis can be selectively inhibited in
mammalian cells with a low concentration of actinomycin (Perry,
1962), it would be possible to assess the amount of dye label in
rRNA versus non-rRNA transcripts in control versus knockdown
cells, based on the presence or absence of the inhibitor. The cells
were incubated with 5-EU for 2 hours, by which time the nuclear
rRNA labeling has attained steady state (Penman, 1966). As shown
in Fig. 3B, the nucleoplasmic 5-EU differential (calculated as the
dye signal level in actinomycin-treated cells subtracted from that of
untreated cells, thus representing mature rRNAs) showed a small
decrease (20%) after 2 days of nucleostemin knockdown compared
with siScr-treated cells. However, cells in which nucleostemin had
been knocked down for 6 days displayed a substantial reduction
(75%) in their nucleoplasmic 5-EU differential signal compared
with siScr-treated cells. Finally, in contrast to a previous report
(Romanova et al., 2009b) showing that nucleostemin depletion
causes a dispersion of the dense fibrillar component (DFC) of
nucleolar structure, which is defined by the protein fibrillarin, we
found no discernible changes in the fibrillarin-labeled DFC
structure in cells in which nucleostemin was knocked down for
2 days (Fig. 3C1), but a disorganized DFC structure was apparent
in some cells after a 6-day knockdown (Fig. 3C2). In support, we
found no changes in the nucleolin-labeled nucleolar structure
in cells treated with siNS for 2 days (Fig. 3D1), but a
disorganized nucleolin-labeled nucleolar structure in some of
the cells treated with siNS for 6 days (Fig. 3D2). These
results indicate that prolonged nucleostemin depletion might
perturb rRNA transcription and processing secondarily to the
induction of the DNA damage response described in the previous
section.
Partial nucleostemin depletion induces a G2/M arrest
We previously found that nucleostemin-haploinsufficient mouse
embryonic fibroblasts and shRNAmir-mediated nucleostemin-
depleted human osteosarcoma cells both display a G2/M-phase
arrest (Meng et al., 2008; Zhu et al., 2006). Because the
nucleostemin depletion in both cases was in the range of 50–
60%, and based on the results of the present study, we speculated
that partial nucleostemin depletion is permissive for S-phase transit
until the G2/M checkpoint. To investigate this possibility, we
tested a range of siRNA concentrations that led to nucleostemin
depletions of 54%, 84% and 92% at the 48-hour time-point
(Fig. 4A1,2). FACS analysis confirmed that the percentage of c-
H2AX+ cells increased in proportion to nucleostemin depletion
(Fig. 4A3). Notably, there was an increase in the percentage of G2/
M-phase cells in samples with the least nucleostemin depletion
(Fig. 4B1). When the nucleostemin depletion was 84%, S-phase
arrest became apparent, with a concomitant decrease in the G2/M-
phase population (Fig. 4B2). These results indicate that cells with a
partial loss of nucleostemin progress through S phase until the G2/
M checkpoint and thus offer an explanation of the seemingly
conflicting findings on the effect of nucleostemin knockdown on
the cell cycle.
GNL3L or GNL2 knockdown contrasts with
nucleostemin depletion
Because human cells contain two other nucleostemin homologs,
GNL3L and GNL2, it was of interest to determine how their
depletion might impact on DNA damage and cell-cycle
progression. Cells were transfected with GNL3L-specific (siG3L)
or GNL2-specific (siGNL2) siRNA duplexes and analyzed
48 hours later. To detect GNL3L and GNL2 proteins, antibodies
were generated to specifically recognize either human GNL3L
(Ab134) or human GNL2 (Ab136). Analysis of western blots
Fig. 1. Loss of nucleostemin increases the number of DNA damage foci as visualized by staining for multiple DNA-damage-response proteins. MDA-
MB-231 cells were treated with scrambled (siScr) or nucleostemin-specific (siNS) siRNA duplexes for 48 hours at 100 nM. (A) Upper left panel, western
blots of nucleostemin and c-H2AX. Protein loading was controlled by the amount of a-tubulin (Tub). NS, nucleostemin. Lower panels, immunofluorescence
with an anti-c-H2AX antibody. Upper-right panel, quantitative measurement of the percentage of c-H2AX+ cells in siScr- and siNS-treated samples.
(B) Percentage of ATR+ cells (left) as determined by using immunofluorescence (right). Panels 1 and 2 show magnified views of the regions outlined in white.
White arrows, examples of ATR+ cells. (C) The percentage of 53BP1+ cells (right) as determined by using immunofluorescence (left). Scale bars: 50 mm (A and
C), 20 mm (B). Bar graphs represent mean6s.e.m.
RESEARCH ARTICLE Journal of Cell Science (2014) 127, 2302–2312 doi:10.1242/jcs.143842
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confirmed that siG3L treatment reduced the amount of GNL3L
protein by .82% but did not increase the amount of c-H2AX
protein (Fig. 5A). FACS analysis showed that only 3.9% of
GNL3L-depleted cells were c-H2AX+, which is slightly higher than
the 1.5% of c-H2AX+ cells in the siScr-treated sample but distinctly
lower than the 19.3% of c-H2AX+ cells in the nucleostemin-
depleted sample (Fig. 5B). In addition, GNL3L-depleted cells differ
from nucleostemin-depleted cells in showing an increase in the
percentage of G2/M-phase cells and a slight decrease in the
percentage of G1/G0 cells (Fig. 5C1,2). Western blotting showed
that a 62% reduction in the amount of GNL2 elicited no change in
c-H2AX protein (Fig. 5D). FACS analysis revealed that 5.4% of
GNL2-depleted cells were c-H2AX+, which is still significantly
lower than for nucleostemin-depleted cells (P,0.001) (Fig. 5E). In
addition, GNL2 depletion led to an increase in the percentage of G2/
M-phase cells and a slight decrease in the percentage of S-phase
cells, indicative of a G2/M arrest (Fig. 5F). These results
demonstrate that depletion of neither GNL3L nor GNL2 elicits as
extensive a DNA damage response as does nucleostemin depletion,
and that depletion of either of these proteins does not trigger the S-
phase arrest seen upon nucleostemin depletion.
Loss of GNL3L perturbs pre-rRNA processing
Given that GNL3L is paralogous to nucleostemin but elicits
minimal DNA damage when depleted, we reasoned that GNL3L
is likely to be the member of this protein pair that has retained the
Fig. 2. S-phase DNA damage is an early event during knockdown of nucleostemin. (A) FACS-based quantification of the percentage of c-H2AX+ cells in
MDA-MB-231 cell samples treated with siScr or siNS (100 nM) for 12, 24 or 48 hours. Data show the mean6s.e.m. (B) Cell-cycle profiles (B1) and
quantitative analyses (n54, B2) of siScr- and siNS-treated MDA-MB-231 cells at different knockdown time-points. The fitted profiles shaded in gray represent
cells with more than 2N copies of chromosomes. (C) Cell-cycle profiles of the c-H2AX+ versus c-H2AX2 cells in nucleostemin-knockdown samples were
quantitatively analyzed by using FACS with anti-c-H2AX and propidium iodide (PI). (D) Based on the analyses shown in C, the percentages of c-H2AX+ cells in
S-phase versus G1/G0-phase in the nucleostemin-knockdown sample were compared at the 12, 24 and 48-hour time-points. Data show the mean6s.e.m.
(E) Immunofluorescent imaging (right) using anti-53BP1 and anti-BrdU antibodies in MDA-MB-231 cells treated with siNS (100 nM) for 48 hours. Quantitative
data (left) represent the mean6s.e.m. of the percentage of 53BP1+ cells in the non-BrdU-labeled (non-S-phase, asterisk) versus BrdU-labeled (S-phase, arrows)
cell populations. Scale bar: 50 mm.
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ribosome synthesis function of the ancestral protein, GNL3. To test
this hypothesis, we determined the levels of rRNA transcripts in
GNL3L-depleted cells (Fig. 6A). GNL3L depletion led to a
substantial increase in the level of the 47S primary transcript,
indicating an inhibition of the 47S-to-45S processing step. In addition,
the differential 5-EU assay revealed a significant (57%) reduction in
nucleoplasmic rRNA after GNL3L knockdown (Fig. 6B). However,
as with short-term (2-day) nucleostemin knockdown, GNL3L
depletion did not alter the fibrillarin-, nucleolin- or nucleostemin-
labeled subnucleolar structures (Fig. 6C,D), indicating that the effect
of the 2-day GNL3L knockdown on 47S-to-45S processing does not
manifest as a change in nucleolar structure such as that known to
occur when transcription of the rDNA is perturbed (Dousset et al.,
2000; Ma and Pederson, 2013).
Overexpression of nucleostemin, but not of GNL3L or GNL2,
confers protection against replication-induced DNA damage
Spontaneous DNA damage can be caused by stalling of the
replication fork, oxidative stress or DNA base hydrolysis. To
determine the type of DNA damage involved, we measured the
sensitivities of control and nucleostemin-depleted cells to
hydoxyurea, H2O2 or UV perturbations that introduce
replication fork stalling, reactive oxygen species and thymine
dimers, respectively. Nucleostemin depletion increased the
sensitivity of MDA-MB-231 cells to HU-induced replication
stalling (P,0.001, repeated measures ANOVA) but not to UV- or
H2O2-induced DNA damage (Fig. 7A). To further investigate the
function of nucleostemin in replication-linked DNA damage, we
performed rescue experiments. Nucleostemin–GFP expression
Fig. 3. Knockdown of nucleostemin has minimal effects on rRNA synthesis or nucleolar integrity at the 48-hour time-point. (A) Left, diagram showing
the pre-rRNA-processing step and the primer positions flanking the processing sites 1 and 2 (PS-1, PS-2). White, black and grey boxes represent 18S, 5.8S and
28S rRNAs, respectively. The PS-1 and PS-2 primer recognition sites are indicated by gray circles. Middle and left panels, qRT-PCR assays of nucleostemin
(NS), PS-1 and PS-2 levels in MDA-MB-231 cells treated with siScr or siNS for 2 days (2d) or 6 days (6d). The expression levels of target transcripts were
quantified by normalizing to the expression of HMG-14. The expression levels of each transcript in the corresponding siScr samples were arbitrarily set as 1.
(B) A modified 5-EU click-chemistry assay was designed to measure the amount of newly synthesized mature rRNA present in the nucleoplasm. The differential
5-EU signals [control (Ctrl) minus actinomycin (ActD)-treated samples] in the nucleoplasm were quantified in MDA-MB-231 cells treated with siScr or siNS for
2 days or 6 days. Data show the mean6s.e.m.; *P,0.01, **P,0.001, ***P,0.0001. (C) Confocal immunofluorescence of the fibrillarin (Fib)-labeled dense
fibrillar component and nucleostemin-labeled structure in siRNA-treated cells at the 2-day and 6-day time-points. (D) Confocal immunofluorescence of nucleolin-
and nucleostemin-labeled nucleolar structures in siRNA-treated cells at the 2-day and 6-day time-points. White dashed lines show nucleus outlines. Scale bars:
10 mm.
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significantly protected cells against replication-linked DNA
damage, whereas neither GNL3L–GFP nor GNL2–GFP was
able to do so (Fig. 7B, upper panel). This rescue effect was
seen only in transfected (GFP-positive) cells in the
nucleostemin–GFP-transfected samples (Fig. 7B, compare
upper and lower panels). Given the high concentration of
nucleostemin protein in the nucleolus, we investigated whether
the protective effect of nucleostemin against replication-linked
DNA damage might occur through some indirect mechanism
requiring the nucleolar localization of nucleostemin. However,
we found that the expression of a version of nucleostemin that
lacked the nucleolus-localization signal (NSdB–GFP) – and
thus accumulated in the nucleoplasm – also conferred
protection against DNA damage (Fig. 7B, upper panel). Thus,
this property of nucleostemin does not require nucleolar
localization and is likely to be a direct effect, or at least one
that occurs in proximity to replication sites. Taken together, the
results of this investigation show that nucleostemin has a
unique role in maintaining genomic stability by protecting
against replication-induced DNA damage, and that it is the
paralogous protein, GNL3L, that has retained the role in
ribosome synthesis established in the ancestral pre-vertebrate
protein.
DISCUSSION
The hypothesis
When nucleostemin was first discovered in rat embryonic neural
stem cells (Tsai and McKay, 2002), the focus was, of course, on
its role as a determinant in the cells, not its evolutionary origin.
The subsequent identification of GNL3L, the mammalian
paralog of nucleostemin, broadened the landscape of possible
functions of these two nucleolar GTP-binding proteins.
Subsequent work on both nucleostemin and GNL3L (Lin
et al., 2010; Ma and Pederson, 2007; Meng et al., 2011a;
Meng et al., 2011b; Meng et al., 2008; Zhu et al., 2009; Zhu
et al., 2006) drew attention to the involvement of both proteins
in cell proliferation, although the direct roles of the proteins
were not rigorously proven. At the same time, evidence appeared
in Drosophila linking the invertebrate protein, GNL3, to
ribosome biosynthesis (Rosby et al., 2009), and another report
implicated mammalian nucleostemin in ribosome biosynthesis
(Romanova et al., 2009a). It was against this background that we
Fig. 4. The knockdown efficiency dictates the nature of the cell-cycle arrest of nucleostemin-depleted cells. (A1) Western blots to show the knockdown
efficiency in MDA-MB-231 cells treated with different concentrations (conc.) of siScr and siNS. Samples were collected at the 48-hour time-point. Relative
nucleostemin intensities (%) between paired siScr and siNS samples are shown below the blots. a-tubulin (Tub) is shown as a loading control. NS, nucleostemin.
(A2) Immunofluorescence performed using anti-nucleostemin and c-H2AX antibodies in siScr- and siNS-treated MDA-MB-231 cells. Nuclear structure and
cell morphology are shown by DAPI staining and differential interference contrast (DIC) imaging, respectively. Scale bars: 10 mm. (A3) FACS-based
quantification of the percentage of c-H2AX+ cells in siScr- and siNS-treated samples. **P,0.001, ***P,0.0001. (B) Cell-cycle profiles and quantitative analyses
(n54) of MDA-MB-231 cells treated with 12.5 nM (B1) or 50 nM (B2) siRNAs for 48 hours. Data show the mean6s.e.m. of three independent experiments.
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launched the present study. Our hypothesis was that mammalian
GNL3L has retained the role of the ancestral protein in ribosome
biosynthesis, whereas the paralogous nucleostemin acquired a
different function or functions. Our findings reveal distinct
activities of mammalian nucleostemin and GNL3L in genome
protection and ribosome biosynthesis, respectively, and strongly
support the hypothesis that nucleostemin functionally diverged
from its vertebrate paralog, GNL3L, and the invertebrate
ortholog, GNL3.
DNA damage, not impairment of ribosome biosynthesis, is an
early event following nucleostemin depletion
As discussed above, whether nucleostemin plays a direct role in
ribosome biogenesis has not been clear. Most previous studies
Fig. 5. Loss of GNL3L or GNL2 causes G2/M arrest with minimal DNA damage. MDA-MB-231 cells were treated with GNL3L-specific (siG3L, A–C) or
GNL2-specific (siGNL2, D–F) siRNA duplexes at 100 nM for 48 hours. (A,D) Western blots of GNL3L, GNL2 and c-H2AX. Protein loading was controlled by the
amount of a-tubulin (Tub). The relative amount of the siRNA-targeted protein is indicated beneath the blots. (B,E) FACS-based quantification of the percentage
of c-H2AX+ cells in siRNA-treated samples. (C,F) Cell-cycle profiles and quantitative analyses (n54) of siRNA-treated MDA-MB-231 cells. Data represent
the mean6s.e.m.
Fig. 6. Loss of GNL3L perturbs the processing of
pre-rRNAs. (A) qRT-PCR assays of GNL3L, PS-1 and
PS-2 levels in MDA-MB-231 cells treated with siScr or
siG3L for 2 days (2d). The expression levels of target
transcripts were quantified by normalizing to the
expression of HMG-14. The expression levels of each
transcript in the siScr samples were arbitrarily set as 1.
(B) The differential 5-EU signals [control (Ctrl) minus
actinomycin (ActD)-treated samples] in the nucleoplasm
were quantified in MDA-MB-231 cells treated with siScr
or siG3L for 2 days (left). Right, immunofluorescence of
5-EU signals in control (siScr) and GNL3L-knockdown
(siG3L) cells with (ActD) or without (Ctrl) treatment with
a low dose of ActD. Data show the mean6s.e.m.
***P,0.0001. (C) Confocal immunofluorescence to
show the fibrillarin (Fib)- and nucleostemin (NS)-labeled
structures in cells treated with siScr or siG3L for 2 days.
(D) Confocal immunofluorescence of the nucleolin- and
nucleostemin-labeled structures in cells treated with
siScr or siG3L for 2 days. White dashed lines show
nucleus outlines. Scale bars: 10 um.
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examined only the terminal results of nucleostemin gene
knockout or knockdown, without resolving the temporal
relationship of the events. This issue applies to both whole-
organism studies (Kudron and Reinke, 2008; Rosby et al., 2009)
and to the nucleostemin-knockdown study of Romanova et al.
(Romanova et al., 2009a) in HeLa cells, in which cells were
analyzed on the 5th day after two rounds of knockdown. Our
timecourse analyses show that nucleostemin depletion triggers
DNA damage and cell-cycle arrest shortly after the initiation of
knockdown (,12 hours). By contrast, the biosynthesis of 47S
and 45S rRNA precursors is not appreciably perturbed within
48 hours of nucleostemin knockdown. Moreover, the differential
5-EU labeling assay reveals only a minor reduction in the steady-
state labeled rRNA species in the nucleoplasm after a 2-day
nucleostemin knockdown. Most relevant to the Romanova et al.
study, we found that the transcription and maturation of rRNAs
are both severely inhibited after 6 days of nucleostemin
knockdown, a period of time that is comparable to their 5-day
knockdown. We also noted that the rRNA labeling kinetics
reported in the study by Romanova et al. were much slower than
those reported in numerous other studies (e.g. Penman, 1966),
suggesting that these 5-day-knockdown cells succumb to
pronounced cytopathic events. This interpretation of their
findings gains further traction given the fact that the 5-day-
knockdown cells display a ,50% decrease in histone 2B, which
substantial literature indicates would elicit a cell-cycle arrest.
There is abundant evidence in the literature showing that
cell-cycle arrest of transformed mammalian cells leads to an
inhibition of rRNA synthesis. Thus, we believe that the
conclusion reached by Romanova et al. might be confounded
by unsuspected issues surrounding the immediate versus long-
term effects of nucleostemin depletion, as well as the
interconnecting relationship between nucleolar function and cell
cycle. Furthermore, while the present investigation was under
way, a parallel study suggested that there is a direct molecular
recruitment of nucleostemin to DNA damage sites, where it
interacts with the DNA repair protein RAD51 (Meng et al., 2013).
This also alerted us to the possibility that nucleostemin is
involved in genome protection and not rRNA synthesis.
The effect of nucleostemin depletion on cell-cycle
progression
The exact effects of nucleostemin depletion on the progression of
the cell cycle vary among different studies. Effects shown include
a G1/S arrest (Dai et al., 2008; Ma and Pederson, 2007; Nikpour
et al., 2009) or a G2/M arrest (Meng et al., 2008; Nikpour et al.,
Fig. 7. Overexpression of nucleostemin, but not of GNL3L or
GNL2, protects against hydroxyurea (HU)-induced DNA damage.
(A) MDA-MB-231 cells treated with siScr or siNS were tested for their
clonogenic survival following treatment with HU, H2O2 or UV. (B) Upper
panel, the percentage of c-H2AX+ cells in the transfected (GFP-
positive) populations of MDA-MB-231 cells transiently overexpressing
GFP, nucleostemin (NS)–GFP, NSdB–GFP (a nucleoplasmic
nucleostemin mutant), GNL3L–GFP or GNL2–GFP, with or without a
24-hour HU treatment. Lower panel, the percentage of c-H2AX+ cells in
the non-transfected (GFP-negative) populations. Differences were
analyzed by repeated measures ANOVA. Data represent the
mean6s.e.m.
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2009; Romanova et al., 2009a; Zhu et al., 2006). This discrepancy
cannot be explained by the status of p53, Rb or p16 in the cell
models used. The present study reveals that the primary cell-cycle
event of nucleostemin depletion is an S-phase arrest and that a
less-efficient knockdown of nucleostemin produces a G2/M-
phase arrest (Fig. 4). This provides a potential resolution to the
contradicting results on cell-cycle arrest reported previously, in
which a near-complete or partial nucleostemin knockdown might
result in an early S-phase (apparent G1/S) arrest, an intra-S-phase
arrest or a late S and G2/M arrest.
The role of nucleostemin in DNA damage protection
When DNA damage occurs as a result of replication stalling,
formation of reactive oxygen species or base hydrolysis, cells
respond by mounting distinct repair mechanisms. The homologous
recombination machinery is the primary mechanism responsible for
the restart and repair of stalled or collapsed replication forks
(Helleday, 2008). The base excision repair (BER) machinery
repairs non-helix-distorting base lesions caused by reactive oxygen
species, alkylation or deamination, and thus BER impairment leads,
experimentally, to sensitivity to H2O2. The nucleotide excision
repair (NER) machinery removes depurinated bases and intra-
strand crosslinks. Cells with dysfunctional NER show an increased
sensitivity to UV-induced damage. Our data show that DNA
damage induced by nucleostemin knockdown preferentially occurs
in S-phase cells. Compared with control cells, nucleostemin-
depleted cells are more sensitive to HU-induced damage but not to
H2O2- or UV-induced damage, and overexpression of nucleostemin
is able to rescue HU-induced DNA damage. These findings suggest
that nucleostemin might safeguard the genomic integrity of actively
dividing cells by promoting the repair of DNA damage that takes
place during DNA replication. Finally, because MDA-MB-231
cells are p53 mutated, the observed genome-protective activity of
nucleostemin is expected to act independently of the MDM2–p53
pathway and is more in synchrony with the obligatory function of
nucleostemin documented in p53-null embryos (Beekman et al.,
2006). This study, and a previous one (Meng et al., 2008),
emphasize that the genome-protective activity of nucleostemin
occurs constitutively, whereas its MDM2-regulatory function takes
place primarily when the protein is mobilized from the nucleolus to
the nucleoplasm under conditions of nucleolar stress or mitotic
transit.
An evolving view of nucleostemin family proteins
The conflicting reports on the role of nucleostemin in cell
proliferation, MDM2–p53 regulation and ribosome biosynthesis
gave rise to the notion that this is a multitasking protein. Our
results suggest that this might not be the case. Instead, the
primary role of nucleostemin might be a genome-protective
function, and the effect of its knockdown on ribosome
biosynthesis might be a secondary consequence. The present
findings can aid in the interpretation of earlier studies in which
invertebrate GNL3 and mammalian nucleostemin have been
investigated. Thus, because genetic deletion of the invertebrate
ortholog, GNL3, was observed to impair ribosome biosynthesis
(Du et al., 2006; Kudron and Reinke, 2008; Rosby et al., 2009),
reports of similar effects of mammalian nucleostemin knockdown
naturally led some investigators to regard nucleostemin as the
mammalian equivalent of invertebrate GNL3. Here, we show that
a significant impairment of ribosome biosynthesis occurs only
after prolonged nucleostemin knockdown, and that it is in fact
GNL3L that plays a major role in rRNA biosynthesis. Thus, the
entire phyletic situation of the nucleostemin family proteins
becomes clear – nucleostemin is the paralog of GNL3L in
mammalian cells, and the latter is the direct descendant of the
invertebrate gene. It is not yet known whether the functional
divergence of nucleostemin from GNL3L and GNL3 is an on-
going event that differs in lower versus higher vertebrate species.
One recent study by Essers and colleagues reported that
nucleostemin mutation in zebrafish (Danio rerio) causes a
reduction in the number of 60S ribosomes as well as p53
stabilization (Essers et al., 2014). Interestingly, they also found
that deleting p53 can rescue the reduced number of 60S
ribosomes in nucleostemin-mutant fish and elevate the number
of 60S ribosomes in wild-type fish, which indicates that the
ribosomal effect seen in nucleostemin-mutant fish might be
explained by the stabilization of p53 as a result of nucleostemin
mutation. By contrast, GNL3L-mutant fish show a decrease in the
number of 80S ribosomes (by 38.5%) that is comparable to that of
nucleostemin-mutant (by 41.5%) and GNL2-mutant (by 45.7%)
fish, as well as a prominent increase in the amount of 47S rRNA
precursor, but without an apparent effect on the amount of newly
synthesized proteins.
In conclusion, this study reports that the DNA damage induced
by nucleostemin knockdown occurs significantly earlier than the
ribosomal effect reported previously, that the cell-cycle profile of
nucleostemin-depleted cells (intra-S versus G2/M arrest) depends
on the level of nucleostemin knockdown and that, in contrast to
nucleostemin knockdown, the loss of human GNL3L causes
ribosomal defects without introducing DNA damage. On the basis
of these new findings, we suggest that, during the evolution of
vertebrate species, GNL3L might have retained the role of its
ancestral gene in ribosome biosynthesis, whereas the paralog,
nucleostemin, acquired a new and unique function in genome
protection.
MATERIALS AND METHODS
Cell culture and siRNA knockdown
The human breast carcinoma cell line MDA-MB-231 was obtained from
the American Type Culture Collection and maintained in monolayer
culture in DMEM plus 10% fetal bovine serum as described previously
(Lin et al., 2010). Target-specific siRNA duplexes were introduced by
transfection using Oligofectamine (Invitrogen, Carlsbad, CA) at 24 hours
after replating. Timecourse studies were performed by incubating cells in
medium containing siRNA (100 nM) for 12, 24 or 48 hours. Dose-
dependent studies were carried out by incubating cells in medium
containing siRNA (12.5 nM, 50 nM or 100 nM) for 48 hours. For the
long-term (6-day) knockdown study, cells were incubated with siRNA
(100 nM) for 24 hours, allowed to recover for 48 hours, treated with
another round of siRNA (100 nM) for 24 hours and allowed to recover
for 48 hours before harvesting. The RNA sequences targeted by the
control (siScr), nucleostemin-specific (siNS), GNL3L-specific (siG3L)
and GNL2-specific (siGNL2) siRNA duplexes were; 59-UGACGA-
UCAGAAUGCGACU-39 (siScr), 59-GAACUAAAACAGCAGCAGA-39
(siNS), 59-CUAUUGCCGCCUUGGUGA A-39 (siG3L) and 59-ACAAA-
GGUCUGGCAGUAUA-39 (siGNL2).
Western blotting
Western blot analyses were performed as described previously and were
repeated twice (Meng et al., 2006; Tsai and McKay, 2005). The primary
antibodies used in this study were rabbit polyclonal antibodies
against human nucleostemin (Ab138), GNL3L (Ab134) and GNL2
(Ab136) (all generated in the Tsai laboratory) c-H2AX (JBW301,
Millipore, Billerica, MA) and a-tubulin (Sigma, St Louis, MO).
Secondary antibodies were conjugated to peroxidase (Jackson
ImmunoResearch, West Grove, PA).
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Immunofluorescence
DNA damage foci were detected by staining with antibodies against c-
H2AX, ATR (N-19, Santa Cruz, Dallas, TX) and 53BP1 (#4937, Cell
Signaling Technology, Danvers, MA). For c-H2AX staining, 1696 and
1113 cells were counted for the siScr and siNS groups, respectively. For
ATR staining, 580 and 592 cells were counted for the siScr and siNS
groups, respectively. For 53BP1 staining, 1572 and 1615 cells were
counted for the siScr and siNS groups, respectively. Nucleoli were
labeled by using anti-fibrillarin antibody (38F3, EnCor, Gainesville, FL)
and anti-nucleolin antibody (4E2, Research Diagnostics, CA). Secondary
antibodies were conjugated with Rhodamine-X or FITC. After fixation in
4% formaldehyde (in all cases except for anti-nucleolin staining) or ice-
cold methanol (nucleolin staining) for 15 minutes at room temperature,
cells were permeabilized with 0.3% Triton X-100 and incubated with
primary and secondary antibodies. To detect S-phase cells, cultures were
treated with bromodeoxyuridine (BrdU, 10mM, Accurate, OBT0030)
30 minutes before harvest and stained with rat anti-BrdU antibody (BU1/
75, Accurate) following treatment with 4N HCl. A total of 780 cells were
randomly selected and analyzed. Fluorescence images were acquired on a
Zeiss LSM510 confocal microscope using the 406 or 636 plan-
apochromat objectives. For analysis of nucleolar structure, images were
captured using the 636plan-apochromat oil objective and scanned with a
5126512 pixel frame size, 56 zoom and an optical thickness of
,1.0 mm. Detector gain and amplifier offset were adjusted to ensure
that all signals were displayed within the linear range. Quantification of
c-H2AX+, ATR+ and 53BP1+ cells was performed using ImageJ software
with a set threshold level, and positive cells were defined as those
showing five or more visible foci. Final data represent the average of
three independent experiments.
Flow cytometry
Cells were washed with PBS, trypsinized, fixed in 72% ice-cold ethanol
for 30 minutes and sequentially stained with c-H2AX antibody (1:2000)
and propidium iodide (PI, 50 ug/ml, Sigma). PI staining was performed
in the presence of 100 mg/ml DNase-free RNase A. Flow cytometry
analyses were conducted using a COULTER EPICS XL flow cytometer
and the XL System II software in the Flow Cytometry Core Facility at the
Texas Children’s Hospital. Cell-cycle profiles were compiled from 26104
gated events and were analyzed using Multi Cycle AV software. All data
represent the average of four independent experiments.
qRT-PCR analysis of rRNA transcripts
Total cell RNA samples (5 mg) were reversed transcribed into first strand
cDNAs using random hexanucleotide primers and Moloney murine
leukemia virus (Mo-MLV) reverse transcriptase. For quantitative
(q)PCR, the DCt values between the target RNA and a reference
mRNA transcript, HMG-14 (high mobility group-14), were determined
by using the MyiQ single-color real-time PCR detection system and
supermix SYBR green reagent. The DDCt values were measured from
three repeats to compare the relative expression levels of target
sequences. The PCR primer sequences were: nucleostemin (annealing
temperature 56 C˚), 59-GAACAAAGCCAAGTCGGG-39 and 59-GTCC-
ACTCTGGACAATGG-39; GNL3L (56 C˚), 59-TACCTTCGGAATG-
AGTTG-39 and 59-TTCAGCTCCAAAGCAGGC-39; PS-1 (62 C˚), 59-
TGCCCTTCGTCCTGGGAAAC-39 and 59-CGCGCGCGGACAAAC-
CCTT-39; PS-2 (62 C˚), 59-GCGCTCTACCTTACCTACCTG-39 and 59-
CCGTCGGCATGTATTAGCTCT-39; and HMG-14 (56–62 C˚), 59-GGC-
AGCAGCGAAGGATAAATC-39 and 59-TTCATCAGAGGCTGGAC-
TCTC-39. The final data represent the average of two independent
knockdown experiments with two qPCR repeats.
Imaging of rRNA synthesis by click chemistry
Synthesis of rRNAs was detected by using the Click-iTTM RNA Alexa
Fluor 488 imaging kit (C10329, Invitrogen) in experiments in which the
synthesis of specifically rRNA was measured by using actinomycin to
selectively inhibit rRNA synthesis (see Results for details of this
experimental strategy). To detect the synthesis of mature rRNAs in the
nucleoplasm, control or knockdown cells were treated with 0.04 mg/ml of
actinomycin for 20 minutes and then incubated for 2 hours with 5-
ethynyl uridine (5-EU) at 1 mM in the continued presence or absence of
actinomycin. The cells were fixed with 4% formaldehyde in PBS for
15 minutes, permeabilized with 0.5% Triton X-100 in PBS for
15 minutes and then incubated with the Click-iTTM reaction cocktail
for 1 hour. The cells were then washed with rinse buffer and DNA was
counterstained with TO-PROH-3 for 30 minutes. The average 5-EU
signal intensity in the nucleoplasm was measured from 27 cells per
experiment and three independent repeats for each condition using the
ImageJ program. The level of nuclear rRNA was determined by the
difference in nucleoplasmic intensity between the actinomycin-treated
and non-treated groups. With 5-EU label times of 2 hours, little label was
seen in the nucleoli, owing to the fact that, after this labeling period, the
nuclear rRNA has been labeled to equilibrium, reflecting RNA mass, and
the minute amounts of pre-rRNA in the nucleoli are only present at
background levels.
Clonogenic survival assay
Cells were treated with the desired siRNA (100 nM) duplexes for
48 hours. After recovering for 24 hours, cells were replated at low
density (55 cells/cm2). At 24 hours, cells were treated for 24 hours with
different concentrations of hydroxyurea or H2O2. For UV irradiation,
cells were washed with PBS, supernatant was removed and cells were
exposed to 254-nm light at doses of 0–20 J/m2. All cultures were then
maintained in normal growth medium for 2 weeks to allow colony
formation. Colonies were visualized by fixing with 3.7% formaldehyde
for 15 minutes at room temperature and staining with 0.05% Crystal
Violet for 30 minutes. Colonies containing 50 or more cells were
counted. Final data represent the average of three independent
experiments and are analyzed by repeated measures ANOVA.
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